US5648084A
(en)
*
|
1990-02-28 |
1997-07-15 |
Guttag; Alvin |
Multiple dosage medicine drop bottle
|
US5472954A
(en)
*
|
1992-07-14 |
1995-12-05 |
Cyclops H.F. |
Cyclodextrin complexation
|
US5684169A
(en)
*
|
1992-11-27 |
1997-11-04 |
Ensuiko Sugar Refining Co., Ltd. |
Cyclodextrin inclusion complex of taxol, and method for its production and its use
|
US5494901A
(en)
*
|
1993-01-05 |
1996-02-27 |
Javitt; Jonathan C. |
Topical compositions for the eye comprising a β-cyclodextrin derivative and a therapeutic agent
|
EP0621036B1
(de)
*
|
1993-04-22 |
1999-03-17 |
Senju Pharmaceutical Co., Ltd. |
Wässrige Arzneizubereitungen enthaltend Argatroban und Cyclodextrin oder Coffein
|
WO1995005199A1
(en)
*
|
1993-08-19 |
1995-02-23 |
Dextran Products Limited |
Pharmaceutical preparation and a process for making same
|
SI9300470A
(en)
*
|
1993-09-10 |
1995-04-30 |
Lek Tovarna Farmacevtskih |
Inclusion complexes of optically active and racemic ibuproxan with cyclodextrin derivates,process for their preparation,pharmaceutical preparations comprising the same and their use
|
US6121276A
(en)
*
|
1994-04-22 |
2000-09-19 |
Pentech Pharmaceuticals, Inc. |
Apomorphine-containing dosage forms for ameliorating male erectile dysfunction
|
ATE312609T1
(de)
*
|
1994-04-22 |
2005-12-15 |
Pentech Pharmaceuticals Inc |
Sublinguale zusammensetzung enthaltend apomorphine zur diagnose der funktionellen impotenz
|
US6395744B1
(en)
|
1994-04-22 |
2002-05-28 |
Queen's University At Kingston |
Method and compositions for the treatment or amelioration of female sexual dysfunction
|
US5683709A
(en)
*
|
1994-05-05 |
1997-11-04 |
Ciba Vision Corporation |
Poly(benzalkonium salt) as an anti-microbial agent for aqueous drug compositions
|
TW438601B
(en)
*
|
1994-05-18 |
2001-06-07 |
Janssen Pharmaceutica Nv |
New mucoadhesive emulsion compositions and a process for the preparation thereof
|
GB2290964A
(en)
*
|
1994-07-08 |
1996-01-17 |
Arto Olavi Urtti |
Transdermal drug delivery system
|
US5525596A
(en)
*
|
1994-10-21 |
1996-06-11 |
Merck & Co., Inc. |
Absorption enhancer/solubilizer combination for improved bioavailability of a zwitterionic compound
|
US5679573A
(en)
*
|
1995-07-27 |
1997-10-21 |
Abbott Laboratories |
Stabilized aqueous steroid immunoassay standards with cyclodextrins
|
FR2738149B1
(fr)
*
|
1995-09-06 |
1997-11-14 |
Chauvin Lab Sa |
Collyre a base d'indometacine pret a l'emploi
|
US5744154A
(en)
*
|
1995-09-06 |
1998-04-28 |
Laboratoire Chauvin S.A. |
Ready-to-use indomethacin-based eye lotion
|
JP2920611B2
(ja)
*
|
1995-12-11 |
1999-07-19 |
株式会社シーエーシー |
皮膚炎の治療外用剤
|
US5773031A
(en)
*
|
1996-02-27 |
1998-06-30 |
L. Perrigo Company |
Acetaminophen sustained-release formulation
|
DE69733664T3
(de)
|
1996-04-19 |
2011-04-14 |
Grifols Inc. (n.d. Ges.d.Staates Delaware), Los Angeles |
Verfahren zur INaktivierung von Viren und Lyophilisierung von Blutproteinen
|
US5906981A
(en)
*
|
1996-06-04 |
1999-05-25 |
Troy Corporation |
Halopropargyl inclusion complexes
|
EP0921793B1
(de)
*
|
1997-03-11 |
2000-10-18 |
Hexal Ag |
Feste, nicht zerfliessbare formulierung von natrium valproat
|
DE19713092A1
(de)
*
|
1997-03-27 |
1998-10-01 |
Wacker Chemie Gmbh |
Komplexe aus Gamma-Cyclodextrin und Retinol bzw. Retinol-Derivaten sowie Verfahren zu ihrer Herstellung und ihre Verwendung
|
US6537537B2
(en)
|
1997-06-12 |
2003-03-25 |
The Procter & Gamble Company |
Water-in-silicone emulsion cosmetic compositions
|
GB9712272D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
GB9712269D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
GB9712271D0
(en)
*
|
1997-06-12 |
1997-08-13 |
Procter & Gamble |
Cosmetic composition
|
US6316010B2
(en)
|
1997-06-12 |
2001-11-13 |
The Procter & Gamble Company |
Cosmetic compositions
|
ATE253941T1
(de)
*
|
1997-06-13 |
2003-11-15 |
Cydex Inc |
Zusammensetzung mit erhöhter lagerstabilität enthaltend cyclodextrin und wirkstoffe oder wirkstoff-vorstufen, die in wasserunlösliche komponenten zersetzt werden
|
US6699849B1
(en)
|
1998-02-23 |
2004-03-02 |
Cyclops, Ehf. |
Cyclodextrin complexes of benzodiazepines
|
NZ505951A
(en)
*
|
1998-02-23 |
2003-02-28 |
Cyclops Ehf |
A method for enhancing the complexation efficiency of a heterocyclic drug with cyclodextrin, by subjecting the heterocycloc drug to chemically reversible ring-opening
|
US6403605B1
(en)
|
1998-05-29 |
2002-06-11 |
Queen's University At Kingston |
Methods for the normalization of sexual response and amelioration of long term genital tissue degradation
|
NZ330726A
(en)
*
|
1998-06-18 |
2000-10-27 |
Dec Res |
Intra-vaginal delivery unit or composition containing a cyclodextrin which improves absorbtion of 17-beta oestradiol or oestradiol benzoate
|
EP1109581A1
(de)
*
|
1998-09-02 |
2001-06-27 |
Allergan Sales, Inc. |
Geschützte cyclodextrin-enthaltende zusammensetzungen
|
US20020198174A1
(en)
*
|
2001-05-07 |
2002-12-26 |
Allergan Sales, Inc. |
Disinfecting and solubilizing steroid compositions
|
GB9822681D0
(en)
*
|
1998-10-16 |
1998-12-09 |
Vitabiotics Ltd |
Method of treatment
|
UA74141C2
(uk)
*
|
1998-12-09 |
2005-11-15 |
Дж.Д. Сірл Енд Ко. |
Фармацевтична композиція на основі тонкоподрібненого еплеренону (варіанти), спосіб її одержання та спосіб лікування розладів, опосередкованих альдостероном (варіанти)
|
US6270755B1
(en)
*
|
1999-05-13 |
2001-08-07 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as toxin binders
|
US6290946B1
(en)
|
1999-05-13 |
2001-09-18 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as toxin binders and antibacterial agents
|
US6555139B2
(en)
|
1999-06-28 |
2003-04-29 |
Wockhardt Europe Limited |
Preparation of micron-size pharmaceutical particles by microfluidization
|
AU5975700A
(en)
*
|
1999-07-02 |
2001-01-22 |
Janssen Pharmaceutica N.V. |
Nasal formulation of an antifungal
|
US7069226B1
(en)
|
1999-07-07 |
2006-06-27 |
Synetic, Incorporated |
Prescription data processing system for determining new therapy starts
|
AUPQ633900A0
(en)
*
|
2000-03-20 |
2000-04-15 |
Jurox Pty Ltd |
Anaesthetic composition
|
SI1278549T1
(sl)
*
|
2000-05-02 |
2009-04-30 |
Theravance Inc |
Sestavek, ki vsebuje ciklodekstrin in glikopeptidni antibiotik
|
CA2314494A1
(en)
|
2000-05-02 |
2001-11-02 |
Geltex Pharmaceuticals, Inc. |
Anionic polymers as species specific antibacterial agents
|
SG98393A1
(en)
|
2000-05-19 |
2003-09-19 |
Inst Materials Research & Eng |
Injectable drug delivery systems with cyclodextrin-polymer based hydrogels
|
FR2809311A1
(fr)
*
|
2000-05-23 |
2001-11-30 |
Chauvin Lab Sa |
Solution ophtalmique a base d'acetazolamide destinee au traitement du glaucome
|
US6468989B1
(en)
*
|
2000-07-13 |
2002-10-22 |
Dow Pharmaceutical Sciences |
Gel compositions containing metronidazole
|
PE20020300A1
(es)
*
|
2000-08-22 |
2002-05-10 |
Pharmacia Corp |
Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
|
GB0027180D0
(en)
*
|
2000-11-07 |
2000-12-27 |
Unilever Plc |
Cosmetic and personal care compositions
|
EP1216713A1
(de)
*
|
2000-12-20 |
2002-06-26 |
Schering Aktiengesellschaft |
Zusammensetzungen von Estrogen-Zyklodextrin Komplexe
|
CN101116666B
(zh)
*
|
2000-12-20 |
2014-01-08 |
拜耳知识产权有限责任公司 |
包含雌激素-环糊精复合物的组合物
|
US20020146409A1
(en)
*
|
2001-01-30 |
2002-10-10 |
Herring Steven W. |
Methods for stabilizing lyophilized blood proteins
|
US20060172007A1
(en)
*
|
2001-05-01 |
2006-08-03 |
Nawaz Ahmad |
Compositions and methods for reducing vaginal pH
|
US20030064103A1
(en)
*
|
2001-05-01 |
2003-04-03 |
Lin Shun Y. |
Compositions and methods for treating vulvovaginitis and vaginosis
|
US20030017207A1
(en)
*
|
2001-05-01 |
2003-01-23 |
Lin Shun Y. |
Compositions and methods for treating vulvovaginitis and vaginosis
|
US20040214797A1
(en)
*
|
2001-05-07 |
2004-10-28 |
Allergan, Inc. |
Preserved pharmaceutical compositions comprising cyclodextrins
|
EP1443969A2
(de)
*
|
2001-10-18 |
2004-08-11 |
Decode Genetics EHF |
Cyclodextrin-nicht-einschlusskomplexe
|
KR20030041577A
(ko)
*
|
2001-11-20 |
2003-05-27 |
디디에스텍주식회사 |
난용성 약물과 치환된 시클로덱스트린을 함유하는고체분산체 및 이를 함유하는 약제학적 조성물
|
US6881726B2
(en)
*
|
2001-12-24 |
2005-04-19 |
Dow Pharmaceutical Sciences |
Aqueous compositions containing metronidazole
|
EP1323432B1
(de)
*
|
2001-12-28 |
2005-08-24 |
Sandra Cosci |
Zyklodextrin-Komplexe mit Kalium Ion Homeostasis Regulatoren
|
US20090215735A1
(en)
*
|
2002-02-25 |
2009-08-27 |
Alcon, Inc. |
Topical solution formulations containing a corticosteroid and a cyclodextrin
|
DE10211192A1
(de)
*
|
2002-03-14 |
2003-09-25 |
Beiersdorf Ag |
Isoflavanoide gegen Hautalterung und Akne
|
US20060105008A1
(en)
*
|
2002-03-28 |
2006-05-18 |
Nawaz Ahmad |
Compositions and methods for reducing vaginal pH
|
US20050163853A1
(en)
*
|
2002-04-19 |
2005-07-28 |
Lajos Szente |
Novel biomaterials their preparation and use
|
US6824763B2
(en)
|
2002-05-30 |
2004-11-30 |
Kimberly-Clark Worldwide, Inc. |
Anti-fungal powder having enhanced excipient properties
|
US7297348B2
(en)
*
|
2002-07-19 |
2007-11-20 |
Omeros Corporation |
Biodegradable triblock copolymers, synthesis methods therefore, and hydrogels and biomaterials made there from
|
MXPA05000687A
(es)
*
|
2002-07-22 |
2005-04-08 |
Genzyme Corp |
Poli (estirenosulfonato potasico y sodico), su fabricacion y sus usos.
|
AU2003299872A1
(en)
*
|
2002-12-20 |
2004-07-22 |
Board Of Regents, The University Of Texas System |
Vmp-like sequences of pathogenic borrelia species and strains
|
DE10260872B4
(de)
|
2002-12-23 |
2013-09-26 |
Beiersdorf Ag |
Verwendung von gelbildendem Polymer, Wasser, Alkohol und Meeresalgenextrakt zur Einstellung von Elastizität und Haftvermögen selbstklebender kosmetischer Polymermatrices
|
US7993654B2
(en)
*
|
2002-12-23 |
2011-08-09 |
Beiersdorf Ag |
Self-adhesive polymer matrix containing sea algae extract
|
DE10260873A1
(de)
*
|
2002-12-23 |
2004-07-15 |
Beiersdorf Ag |
Selbstklebende Polymermatrix mit einem Gehalt an Meeresalgenextrakt und Glycerin
|
US6933289B2
(en)
|
2003-07-01 |
2005-08-23 |
Allergan, Inc. |
Inhibition of irritating side effects associated with use of a topical ophthalmic medication
|
EP1709975A1
(de)
*
|
2003-07-10 |
2006-10-11 |
Kyowa Hakko Kogyo Co., Ltd. |
Tablette und herstellungsverfahren dafür
|
KR20060041254A
(ko)
*
|
2003-07-24 |
2006-05-11 |
아스텔라스세이야쿠 가부시키가이샤 |
퀴놀론 유도체 또는 그의 염
|
US20050065062A1
(en)
*
|
2003-09-24 |
2005-03-24 |
3M Innovative Properties Company |
Method of formulating a pharmaceutical composition
|
US20060141049A1
(en)
*
|
2003-11-12 |
2006-06-29 |
Allergan, Inc. |
Triamcinolone compositions for intravitreal administration to treat ocular conditions
|
US20050101582A1
(en)
*
|
2003-11-12 |
2005-05-12 |
Allergan, Inc. |
Compositions and methods for treating a posterior segment of an eye
|
US20070224278A1
(en)
*
|
2003-11-12 |
2007-09-27 |
Lyons Robert T |
Low immunogenicity corticosteroid compositions
|
US20070020298A1
(en)
*
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether gamma-cyclodextrin and corticosteroid
|
US20070020299A1
(en)
|
2003-12-31 |
2007-01-25 |
Pipkin James D |
Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
|
RU2390330C2
(ru)
|
2003-12-31 |
2010-05-27 |
Сайдекс, Инк. |
Ингаляционная препаративная форма, содержащая простой сульфоалкиловый эфир гамма-циклодекстрина и кортикостероид
|
JP2007518804A
(ja)
|
2004-01-20 |
2007-07-12 |
アラーガン、インコーポレイテッド |
トリアムシノロンアセトニドおよびヒアルロン酸を好ましく含有する眼局所治療用組成物
|
US20050234018A1
(en)
*
|
2004-04-15 |
2005-10-20 |
Allergan, Inc. |
Drug delivery to the back of the eye
|
MXPA06012240A
(es)
|
2004-04-23 |
2007-01-31 |
Cydex Inc |
Formulacion para inhalador de polvo seco que contiene eter sulfoalquilico-ciclodextrina.
|
US20050244472A1
(en)
*
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Intraocular drug delivery systems containing excipients with reduced toxicity and related methods
|
US8147865B2
(en)
|
2004-04-30 |
2012-04-03 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
US8119154B2
(en)
|
2004-04-30 |
2012-02-21 |
Allergan, Inc. |
Sustained release intraocular implants and related methods
|
US20050272700A1
(en)
*
|
2004-05-10 |
2005-12-08 |
Servet Buyuktimkin |
Topical treatment and prevention of human papilloma virus (HPV) infection
|
BRPI0513243B8
(pt)
*
|
2004-07-12 |
2021-05-25 |
Allergan Inc |
composições oftálmicas e respectivos usos
|
WO2006011044A1
(en)
*
|
2004-07-22 |
2006-02-02 |
Pfizer Products Inc. |
Amorphous cyclodextrin compositions
|
ES2369554T3
(es)
*
|
2004-09-24 |
2011-12-01 |
Rfe Pharma Llc |
Carboxi-amido-triazoles para el tratamiento local de enfermedades oculares.
|
RU2362785C2
(ru)
*
|
2004-09-27 |
2009-07-27 |
Карджилл, Инкорпорейтед |
Комплексы с включением циклодекстрина и способы их получения
|
WO2006043965A1
(en)
*
|
2004-10-14 |
2006-04-27 |
Allergan, Inc. |
Therapeutic ophthalmic compositions containing retinal friendly excipients and related methods
|
US20060093675A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Mathew Ebmeier |
Intravaginal treatment of vaginal infections with metronidazole compositions
|
US8296162B1
(en)
|
2005-02-01 |
2012-10-23 |
Webmd Llc. |
Systems, devices, and methods for providing healthcare information
|
RU2008101420A
(ru)
*
|
2005-06-13 |
2009-07-20 |
Карджилл, Инкорпорейтед (Us) |
Циклодекстриновые комплексы включения и способы их получения
|
KR20080023684A
(ko)
*
|
2005-06-13 |
2008-03-14 |
카아길, 인코포레이팃드 |
시클로덱스트린 포접 착물 및 이의 제조 방법
|
US20080003296A1
(en)
*
|
2005-07-11 |
2008-01-03 |
Ketner Rodney J |
Amorphous Cyclodextrin Compositions
|
US7893040B2
(en)
|
2005-07-22 |
2011-02-22 |
Oculis Ehf |
Cyclodextrin nanotechnology for ophthalmic drug delivery
|
WO2007047253A2
(en)
*
|
2005-10-11 |
2007-04-26 |
Eastman Chemical Company |
Pharmaceutical formulations of cyclodextrins and antifungal azole compounds
|
MX348982B
(es)
|
2005-10-26 |
2017-07-06 |
Cydex Pharmaceuticals Inc |
Composiciones de eter sulfoalquilico-ciclodextrina y metodos de preparacion de las mismas.
|
US7629331B2
(en)
|
2005-10-26 |
2009-12-08 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
|
US20070238789A1
(en)
*
|
2006-03-31 |
2007-10-11 |
Chin-Ming Chang |
Prednisolone acetate compositions
|
EP2027136A4
(de)
*
|
2006-06-13 |
2011-08-03 |
Cargill Inc |
Grossteilige cyclodextrin-einschlusskomplexe und verfahren zu deren herstellung
|
US8668676B2
(en)
*
|
2006-06-19 |
2014-03-11 |
Allergan, Inc. |
Apparatus and methods for implanting particulate ocular implants
|
WO2008019284A1
(en)
*
|
2006-08-04 |
2008-02-14 |
Decode Genetics Ehf |
Phenoxymethylalkyne inhibitors of lta4h for treating inflammation
|
US9039761B2
(en)
|
2006-08-04 |
2015-05-26 |
Allergan, Inc. |
Ocular implant delivery assemblies with distal caps
|
US8115005B2
(en)
|
2006-08-04 |
2012-02-14 |
Decode Genetics Ehf. |
Pyrazolylphenyl and pyrrolylphenyl inhibitors of LTA4H for treating inflammation
|
US7989480B2
(en)
*
|
2006-08-04 |
2011-08-02 |
Decode Genetics Ehf |
Aryl amino acid derivatives as inhibitors for treating inflammation
|
JP2010514794A
(ja)
*
|
2006-12-27 |
2010-05-06 |
カーギル インコーポレイテッド |
シクロデキストリン封入複合体および該複合体を調製する方法
|
US8380530B2
(en)
|
2007-02-02 |
2013-02-19 |
Webmd Llc. |
Personalized health records with associative relationships
|
ATE530188T1
(de)
*
|
2007-03-02 |
2011-11-15 |
Univ Wollongong |
Zusammensetzungen und verfahren zur abgabe von mitteln gegen krebs
|
EP3766493B1
(de)
|
2007-04-27 |
2023-08-23 |
CyDex Pharmaceuticals, Inc. |
Methode zur stabilisierung von clopidogrel unter verwendung von sulfoalkylethercyclodextrin
|
US20080283693A1
(en)
*
|
2007-05-15 |
2008-11-20 |
Evans Michael J F |
Propulsion apparatus and system
|
EP2550967A1
(de)
*
|
2007-07-11 |
2013-01-30 |
Fertin Pharma A/S |
Komprimierte Kaugummitablette mit Geschmacksmaskierungsmittel
|
WO2009006898A1
(en)
*
|
2007-07-11 |
2009-01-15 |
Fertin Pharma A/S |
Stable medicated chewing gum comprising cyclodextrin inclusion complex
|
US7635773B2
(en)
|
2008-04-28 |
2009-12-22 |
Cydex Pharmaceuticals, Inc. |
Sulfoalkyl ether cyclodextrin compositions
|
US20100105750A1
(en)
*
|
2008-10-23 |
2010-04-29 |
Nycomed Us Inc. |
Stable metronidazole gel formulations
|
US10463677B2
(en)
|
2008-11-07 |
2019-11-05 |
Cydex Pharmaceuticals, Inc. |
Composition containing sulfoalkyl ether cyclodextrin and latanoprost
|
WO2010059836A1
(en)
|
2008-11-20 |
2010-05-27 |
Decode Genetics Ehf |
Substituted aza-bridged bicyclics for cardiovascular and cns disease
|
US8545554B2
(en)
*
|
2009-01-16 |
2013-10-01 |
Allergan, Inc. |
Intraocular injector
|
JP5808739B2
(ja)
|
2009-05-13 |
2015-11-10 |
サイデックス・ファーマシューティカルズ・インコーポレイテッド |
プラスグレル及びシクロデキストリン誘導体を含む医薬組成物並びにその製造方法及び使用方法
|
US11020363B2
(en)
|
2009-05-29 |
2021-06-01 |
Cydex Pharmaceuticals, Inc. |
Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods of making and using the same
|
NZ596515A
(en)
|
2009-05-29 |
2014-03-28 |
Cydex Pharmaceuticals Inc |
Injectable melphalan compositions comprising a cyclodextrin derivative and methods of making and using the same
|
US8658129B2
(en)
*
|
2009-06-04 |
2014-02-25 |
General Electric Company |
Agents and methods for the imaging of myelin basic protein
|
US9968564B2
(en)
|
2009-06-05 |
2018-05-15 |
Intercontinental Great Brands Llc |
Delivery of functional compounds
|
US20100310726A1
(en)
|
2009-06-05 |
2010-12-09 |
Kraft Foods Global Brands Llc |
Novel Preparation of an Enteric Release System
|
US8859003B2
(en)
|
2009-06-05 |
2014-10-14 |
Intercontinental Great Brands Llc |
Preparation of an enteric release system
|
HUP0900698A2
(en)
|
2009-11-06 |
2011-06-28 |
Richter Gedeon Nyrt |
Pharmaceutical compositions of enhanced stability containing drospirenone and ethynyl estradiol and process for their preparation
|
US10328152B2
(en)
|
2011-06-16 |
2019-06-25 |
Nayan Patel |
Method for stabilization and delivery of therapeutic molecules
|
DK2814849T3
(da)
|
2012-02-15 |
2020-03-09 |
Cydex Pharmaceuticals Inc |
Fremgangsmåde til fremstilling af cyclodextrin-derivater
|
CA2865950C
(en)
|
2012-02-28 |
2016-12-20 |
Cydex Pharmaceuticals, Inc. |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
NZ707323A
(en)
|
2012-10-22 |
2018-11-30 |
Cydex Pharmaceuticals Inc |
Alkylated cyclodextrin compositions and processes for preparing and using the same
|
WO2014066304A1
(en)
|
2012-10-22 |
2014-05-01 |
Egenix, Inc. |
Compositions and methods for treating or preventing diseases or disorders associated with misregulated eif4e
|
US8859005B2
(en)
|
2012-12-03 |
2014-10-14 |
Intercontinental Great Brands Llc |
Enteric delivery of functional ingredients suitable for hot comestible applications
|
BR112015031249A2
(pt)
|
2013-06-13 |
2017-07-25 |
Veroscience Llc |
método de tratamento, método para tratar um distúrbio metabólico ou um elemento chave do mesmo, método para normalizar um ritmo diário de liberação de dopamina no sumn, método para estimular a liberação de dopamina de neurônios dopaminérgicos no sumn de um indivíduo e composição farmacêutica
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
WO2016029179A1
(en)
|
2014-08-22 |
2016-02-25 |
Cydex Pharmaceuticals, Inc. |
Fractionated alkylated cyclodextrin compositions and processes for preparing and using the same
|
CA2936741C
(en)
|
2014-10-31 |
2018-11-06 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
DE202016100357U1
(de)
*
|
2016-01-27 |
2016-03-09 |
Peter Sommer |
Pharmazeutische Zubereitung und deren Verwendung bei viralen, entzündlichen Erkrankungen der oberen Atemwege
|
EP3573664A4
(de)
|
2017-01-27 |
2020-11-11 |
Innovative Nano & Micro Technologies Pvt Ltd (INM Technologies) |
Acetazolamidhaltige ophthalmische lösung
|
CN111093626A
(zh)
*
|
2017-08-29 |
2020-05-01 |
费森尤斯卡比肿瘤学有限公司 |
培美曲塞的稳定的液体组合物
|
US20210386067A1
(en)
*
|
2018-10-24 |
2021-12-16 |
Adama Makhteshim Ltd. |
Use of cyclodextrins as agrochemical delivery system
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
CN114040766A
(zh)
|
2019-07-01 |
2022-02-11 |
奥库里斯公司 |
用于稳定包含药物的水性组合物pH的方法
|
EP4149427A1
(de)
|
2020-06-11 |
2023-03-22 |
Sentiss Pharma Private Limited |
Ophthalmische zusammensetzungen mit einer kombination aus einem antibakteriellen fluorchinolonmittel und einem entzündungshemmenden mittel
|